Intas’ Accord Pens $165m Deal To Bring In Bio-Thera’s Golimumab In The US

Accord Continues Building Presence Through Deals; Follows EMA Acceptance For Biosimilar

 
• By Dean Rudge
  
Agreement business handshake partnership deal as a solution strategy with a team coming together out of tangled twisted roads on to a bridge to find a common goal.
Shutterstock

More from Deals

More from Products